Ando Fumitaka, Yasui Osamu, Hirose Hiroshi, Ohba Norio
EyeCare Nagoya, Nagoya Dia Building 3, Meieki 3-13-15, Nakamura-ku, 450-0002 Nagoya, Japan.
Graefes Arch Clin Exp Ophthalmol. 2004 Dec;242(12):995-9. doi: 10.1007/s00417-004-0864-4. Epub 2004 Jul 17.
To report anatomic and visual outcomes of vitrectomy and indocyanine green (ICG)-assisted peeling of the retinal internal limiting membrane (ILM) in the treatment of diffuse diabetic macular edema.
In a retrospective interventional case series, 15 eyes of 11 patients with refractory diffuse diabetic macular edema underwent pars plana vitrectomy with removal of the ILM, which was stained by intravitreal injection of ICG (0.1-0.2 ml of 0.5% ICG), performed by a single surgeon. The patients were followed up for 14-28 months (mean 20.5 months). The main outcome measures were assessment of macular edema by optical coherence tomography and determination of visual acuity and visual field.
Intravitreal ICG visualized the ILM to facilitate complete removal of the structure. Qualitative assessment of optical coherence tomography images at the end of follow-up revealed that retinal thickness in the macula appeared nearly normal with or without reappearance of foveal pit in 11 of the 15 eyes (73.3%), decreased in 3 eyes (20.0%), and did not change in 1 eye (6.6%). Best-corrected visual acuity at the end of follow-up improved by 2 lines or more in 4 eyes (26.7%), virtually unchanged in 6 eyes (40.0%), and deteriorated by 2 lines or more in 5 eyes (26.7%). The mean logMAR visual acuity was 0.680 (approximately 12/60) preoperatively and 0.812 (approximately 9/60) postoperatively, the difference being not statistically significant (paired t-test, P=0.445). Seven (46.7%) of the 15 eyes developed optic nerve atrophy that occurred gradually within 6 months after surgery and caused irreversible peripheral visual field defect predominantly affecting the nasal field.
Intravitreal application of ICG is beneficial in uneventful ILM peeling to help resolution of diffuse diabetic macular edema, but it may potentially damage the optic nerve fibers and lead to unfavorable visual outcomes.
报告玻璃体切除术联合吲哚菁绿(ICG)辅助剥除视网膜内界膜(ILM)治疗弥漫性糖尿病性黄斑水肿的解剖学和视觉效果。
在一项回顾性介入病例系列研究中,11例难治性弥漫性糖尿病性黄斑水肿患者的15只眼接受了玻璃体切除术并剥除ILM,ILM通过玻璃体腔内注射ICG(0.5%ICG 0.1 - 0.2 ml)染色,由同一位外科医生操作。对患者进行了14 - 28个月(平均20.5个月)的随访。主要观察指标包括通过光学相干断层扫描评估黄斑水肿情况以及测定视力和视野。
玻璃体腔内注射ICG使ILM显影,便于完全去除该结构。随访结束时对光学相干断层扫描图像的定性评估显示,15只眼中有11只眼(73.3%)黄斑区视网膜厚度接近正常,无论有无中心凹坑再次出现;3只眼(20.0%)视网膜厚度降低;1只眼(6.6%)视网膜厚度未改变。随访结束时,4只眼(26.7%)最佳矫正视力提高2行或更多;6只眼(40.0%)视力基本无变化;5只眼(26.7%)视力下降2行或更多。术前平均logMAR视力为0.680(约12/60),术后为0.812(约9/60),差异无统计学意义(配对t检验,P = 0.445)。15只眼中有7只眼(46.7%)在术后6个月内逐渐出现视神经萎缩,并导致主要影响鼻侧视野的不可逆周边视野缺损。
玻璃体腔内应用ICG有利于顺利剥除ILM,有助于弥漫性糖尿病性黄斑水肿的消退,但可能对视神经纤维造成潜在损害并导致不良视觉效果。